11 reports

Rheumatoid Arthritis Drugs Market by Drug Class (Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, and Others), Route of Administration (Oral and Parenteral), and Sales Channel (Prescription-based Drugs, and Over-the-counter Drugs): Global Opportunity Analysis and Industry...

  • Arthritis
  • Anti Rheumatic
  • World

Anti-Rheumatics Market by Drug Class (Disease Modifying Anti-Rheumatic Drugs (DMARD’s), Nonsteroidal Anti-Inflammatory Drugs (NSAID’s), Corticosteroids, Uric Acid Drugs, and Others), Type (Prescription-Based Drugs and Over-the-Counter Drugs): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global anti-rheumatics...

  • Anti Rheumatic
  • Analgesic
  • Arthritis
  • World
  • APAC
  • Europe

The global biologics market reached a value of US$ 294 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 501.9 Billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...

  • Arthritis
  • Pharmaceutical
  • Healthcare
  • Chronic Disease
  • Research And Development
  • Biopharmaceutical
  • Biotech Diagnostics
  • Digestive System Disorder
  • Anti Rheumatic
  • Protein Therapy
  • Biochemical
  • Autoimmune Disease
  • World

Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, and Intas Pharmaceuticals. The global hydroxychloroquine market is expected to grow from $0.93 billion in 2020 to $1.02 billion in 2021 at a compound annual growth rate (CAGR)...

  • Anti Rheumatic
  • World

Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis and Intas Pharmaceuticals. The global hydroxychloroquine market is expected to grow from $1.68 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR)...

  • Anti Rheumatic
  • World

The global anti-rheumatics market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Healthcare
  • Musculoskeletal Disorder
  • Pathology
  • Arthritis
  • Drug Delivery
  • Anti Rheumatic
  • In-Store Retail
  • Autoimmune Disease
  • World
  • Health Expenditure

Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, and Intas Pharmaceuticals. The global hydroxychloroquine market is expected to grow from $718 million in 2019 to $980.1 million in 2020 at a compound annual growth rate (CAGR)...

  • Anti Rheumatic
  • World

Global antirheumatics market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases help increase the demand for various arthritis treatments. Global antirheumatics market is expected to be worth USD 56.88 billion by 2023. As per NAVADHI...

  • Pharmaceutical
  • Anti Rheumatic
  • World

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions Treatment options for the AS include medication, exercise, physical...

  • Monoclonal Antibody
  • Anti Rheumatic
  • Autoimmune Disease
  • United States

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions Current treatments of RA aim to relieve the symptoms of the disease...

  • Anti Rheumatic
  • Arthritis
  • Monoclonal Antibody
  • Autoimmune Disease
  • United States

Rheumatoid Arthritis - Heat Map and Analysis Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. Disease progression results in stiffness and pain, especially in the hands and feet, which hinders the mobility of the patient and can...

  • Therapy
  • Anti Rheumatic
  • Pharmaceutical
  • Arthritis
  • World
  • United States
  • North America
  • Mortality Rate